Linoride 25mg (20 Tablet / Pack)
A selective oral dopaminergic prokinetic tablet indicated for managing functional dyspepsia, gastroparesis, and gastrointestinal dysmotility.
Linoride 25mg (20 Tablet / Pack) contains Levosulpiride, a substituted benzamide structured to function as a highly selective antagonist of dopamine $D_2$ and $D_3$ receptors in both the central nervous system and the gastrointestinal tracts. By blocking these localized inhibitory dopamine pathways, it facilitates unhindered cholinergic transmission, accelerating gastric emptying and maximizing upper GI motility to treat functional dyspepsia and irritable bowel syndrome.
Purpose
Blocks central and peripheral dopamine D2/D3 receptors to enhance gastrointestinal smooth muscle contractions and improve digestive transit.
Ingredients
Levosulpiride 25mg
Warnings
Administer the tablet strictly 15 to 30 minutes before consuming a main meal to ensure maximum baseline therapeutic efficacy. Absolutely contraindicated in individuals with active gastrointestinal bleeding, mechanical intestinal obstructions, or perforations. Completely avoid prescribing to patients with a documented medical history of epilepsy, severe manic states, or pheochromocytoma. Closely monitor for endocrine shifts, as the drug's mechanism can raise serum prolactin levels, precipitating hyperprolactinemia.
Side Effects
Central nervous system effects including mild daytime drowsiness, transient lightheadedness, or physical fatigue. Endocrine changes such as galactorrhea, gynecomastia, or marked structural irregularities in the female menstrual cycle. Minor extrapyramidal symptoms including low-grade physical restlessness, minor tremors, or transient muscle stiffness. Occasional gastrointestinal adjustments such as mild dryness of the oral mucosa, increased salivation, or brief constipation.
Storage Instructions
Store below 25°C in a cool, dry place, ensuring the tablets remain sealed within their original protective blister pack.
| Status | Active |